Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Lymphopenia × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Leukemia, Myeloid, Acute 4 Breast Neoplasms 4 Lung Neoplasms 3 Neoplasm Metastasis 2 Tissue Adhesions 1 Solid Tumor Refractory to Standard Therapy 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Platinum Resistant Ovarian Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ototoxicity 1 Neutropenia 1 Neoplasms 1 Myoma 1 Myelodysplastic Syndromes 1 Melanoma 1 Lymphopenia 1 Locally Advanced Cervical Cancer 1 Limited Stage Small Cell Lung Cancer 1 Leiomyoma 1 Hearing Loss 1 Febrile Neutropenia 1 Fatigue 1 Digestive Tract 1

Interventions

Sodium Chloride 1 Interleukin-7 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04426201 2024-04-11

ILIAD-7-US-O

Revimmune

Phase 2 Terminated

COVID-19, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡